| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Hull Hans is a Chief Business Officer at PLIANT THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $311K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sell | 15,936 | $11.20 | $178,500.73 | -7.0% | -87.0% | -88.5% | |
| Jul 10, 2024 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sell | 9,900 | $11.56 | $114,444.00 | -4.2% | +1.4% | -87.4% | |
| Jan 17, 2024 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sell | 9,786 | $17.23 | $168,612.78 | -5.0% | -25.7% | -35.0% | |
| Aug 4, 2023 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sale+OE | 34,919 | $20.01 | $698,580.50 | -5.4% | -25.4% | -31.2% | |
| Jul 17, 2023 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sell | 17,937 | $18.01 | $323,029.23 | -7.6% | -13.7% | -24.3% | |
| Mar 30, 2023 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sell | 9,036 | $26.52 | $239,642.85 | -4.3% | -28.3% | -43.9% | |
| Dec 20, 2022 | PLRX Pliant Therapeutics, Inc. | Chief Business Officer | Sell | 8,748 | $19.10 | $167,107.80 | -6.0% | +45.1% | -14.4% |